Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: WuXi PharmaTech | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: WuXi PharmaTech

Revenues up 25% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi PharmaTech
 
4Q Revenues: $157.2 million (+25%)

4Q Earnings: $32.9 million (+38%)

FY Revenues: $578.1 million (+16%)

FY Earnings: $114.6 million (+32%)

Comments: Laboratory Services revenue in the quarter grew 15% to $119.4 million, driven by drug discovery and development services, with China-based revenues up 18% to $95.8 million, and U.S.-based revenues up 6% to $23.6 million. Manufacturing Services revenue was up 73% to $37.8 million, driven by strong demand in both research manufacturing and commercial manufacturing compared to 4Q12.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics